PHRM 561 - Integrated Therapeutics: Oncology

Prerequisites, PHRM 503, PHRM 546, PHRM 549, PHRM 552, PHRM 578, PHRM 681, doctor of pharmacy major. Cancer is the second cause of death in the United States. Pharmacists play a very significant role in caring of cancer patients, particularly in the areas of support care to lessen patients’ pain and suffering while they are going through their treatments as well as the end-of-life stage. This course utilizes integrated, interdisciplinary approach to apply the principles of pathophysiology, medicinal chemistry, pharmacology, pharmacokinetics, immunology, toxicology, clinical sciences, and social/behavioral/administrative pharmacy sciences for the prevention and therapeutic management of the common hematologic malignancies, solid tumors, and hematologic disorders, with emphasis in supportive care. The hope is to empower the student pharmacists with self-learning attitudes and critical thinking skills to use for the rest of their professional lives. (Offered every year.) 4 credits